QUINIDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Quinidex, and what generic alternatives are available?
Quinidex is a drug marketed by Wyeth Pharms Inc and is included in one NDA.
The generic ingredient in QUINIDEX is quinidine sulfate. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the quinidine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinidex
A generic version of QUINIDEX was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINIDEX?
- What are the global sales for QUINIDEX?
- What is Average Wholesale Price for QUINIDEX?
Summary for QUINIDEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 4,856 |
| DailyMed Link: | QUINIDEX at DailyMed |
US Patents and Regulatory Information for QUINIDEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | QUINIDEX | quinidine sulfate | TABLET, EXTENDED RELEASE;ORAL | 012796-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
